Open access · OA
via Europe PMC
Advances in the clinical application of mesenchymal stem cells for neurological disorders.
Jamali MC, Shafie A, Alqahtani AJ, Al-Samawi RI, Alyami HM, Ashour AA, Felemban MF, Mansuri N, Tayeb FJ, Ahmad I, Mudhafar M, Sheweita SA.
Stem cell research & therapy · 2026
Abstract
Therapeutic approaches employing mesenchymal stem cells (MSCs) have emerged as a promising avenue for investigating treatments for neurological disorders. This strategy aims to capitalize on the biological properties of MSCs to support the repair of damaged neural tissue and modulate pathological processes. This review provides a comprehensive overview of the current clinical evidence regarding MSC applications in major neurological disorders, including Parkinson's disease (PD), Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), stroke, spinal cord injury (SCI), and other pertinent disorders. Across clinical studies, MSC administration has generally demonstrated a favorable safety profile and procedural feasibility. However, therapeutic efficacy remains variable and inconsistent across trials. Importantly, differences in MSC sources, manufacturing procedures, delivery routes, dosing strategies, and patient selection contribute substantially to the heterogeneity of reported outcomes. Therefore, the current body of evidence supports the safety of MSC-based interventions, but their clinical effectiveness has not yet been consistently demonstrated. Future progress will depend largely on the standardization of cell preparation and treatment protocols, improved biomarker-driven patient stratification, and rigorously designed large-scale randomized trials.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1186/s13287-026-05229-5
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
MC, J., A, S., AJ, A., RI, A., HM, A., AA, A., MF, F., N, M., FJ, T., I, A., M, M., & SA., S. (2026). Advances in the clinical application of mesenchymal stem cells for neurological disorders. <em>Stem cell research & therapy</em>. https://doi.org/10.1186/s13287-026-05229-5
Vancouver
MC J, A S, AJ A, RI A, HM A, AA A, et al. Advances in the clinical application of mesenchymal stem cells for neurological disorders. Stem cell research & therapy. 2026. doi:10.1186/s13287-026-05229-5.
BibTeX
@article{jamali2026Advanc,
title = {Advances in the clinical application of mesenchymal stem cells for neurological disorders.},
author = {Jamali MC and Shafie A and Alqahtani AJ and Al-Samawi RI and Alyami HM and Ashour AA and Felemban MF and Mansuri N and Tayeb FJ and Ahmad I and Mudhafar M and Sheweita SA.},
journal = {Stem cell research & therapy},
year = {2026},
doi = {10.1186/s13287-026-05229-5},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stem Cell Research & Therapy 2026
Open access · CC-BY
Advances in the clinical application of mesenchymal stem cells for neurological disorders
Signal Transduction and Targeted Therapy 2022
Open access · CC-BY
Stem cell-based therapy for human diseases
Frontiers in aging 2026
Open access · OA
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.
Tissue Engineering Part B Reviews 2018
Citation only
Mesenchymal Stem Cell Functionalization for Enhanced Therapeutic Applications
Advanced Science 2021
Open access · CC-BY
Mesenchymal Stem Cells for Neurological Disorders
Neural Regeneration Research 2024
Open access · CC-BY